All articles by Praveen Duddu

  1. Deals this week: ExpreS2ion Biotech Holding, Arbutus Biopharma, Intrexon

    ExpreS2ion Biotech Holding, a biopharmaceutical company based in Denmark, intends for a rights offering of 2,400,403 shares at a price…
    Read More…

    19 Jan
  2. Deals this week: China Meheco, Recordati, Novartis

    China Meheco intends to form a Chinese pharmaceutical joint venture (JV) through its subsidiary with a capital of CNY10m ($1.51m). To…
    Read More…

    22 Dec
  3. M&As this week: Strides Pharma Asia, GlaxoSmithKline

    Strides Pharma Asia has agreed to purchase a 55% stake in South African pharmaceutical company Trinity Pharma for R55m ($4.31m)….
    Read More…

    22 Dec
  4. Report: Multiple sclerosis disease-modifying therapies market to witness CAGR of 2.9%

    Sales of multiple sclerosis (MS) disease-modifying therapies (DMTs) are projected to grow from $19.1bn in 2016 to $25.3bn in 2026,…
    Read More…

    15 Dec
  5. Deals this week: Revance Therapeutics, GW Pharmaceuticals, Valeant Pharmaceuticals International

    Revance Therapeutics intends to raise $175m through an underwritten public offering of the shares of its common stock. Underwriters will…
    Read More…

    8 Dec
  6. M&As this week: CVS Health Corporation, NeuroSearch

    CVS Health Corporation (CVS) has agreed to acquire the entire outstanding shares of Aetna for a total consideration of $77bn….
    Read More…

    8 Dec
  7. Deals this week: Eris Lifesciences, Sichuan Languang Development, Xiangxue Pharmaceutical, Navamedic

    Eris Lifesciences has reached an agreement to purchase Strides Shasun’s Indian generics business for $76.73m. Under the agreement, Eris will take…
    Read More…

    24 Nov
  8. Report: Singapore’s pharmaceutical market to witness 5% CAGR up to 2021

    Singapore’s pharmaceutical market is expected to increase from $903m in 2016 to $1.15bn in 2021 in value, representing a compound…
    Read More…

    24 Nov
  9. M&As this week: Caligor Rx, Zhejiang Jolly Pharmaceutical

    US-based pharmacy Caligor Rx has taken over clinical trial material management services provider The Coghlan Group for an undisclosed sum. Caligor…
    Read More…

    24 Nov
  10. Report: Venezuela’s economic crisis to hit domestic pharmaceutical market

    Economic and political turmoil in Venezuela is anticipated to affect the growth rate of the domestic pharmaceutical market, according to…
    Read More…

    17 Nov